{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:27:18Z","timestamp":1773012438614,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.clinthera.2010.11.001","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T10:47:42Z","timestamp":1291114062000},"page":"2097-2105","source":"Crossref","is-referenced-by-count":7,"title":["Relative bioavailability of generic and branded acetylcysteine effervescent tablets: A single-dose, open-label, randomized-sequence, two-period crossover study in fasting healthy chinese male volunteers"],"prefix":"10.1016","volume":"32","author":[{"given":"Yan-Mei","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Ying","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang-Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ping","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Xiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shui-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2010.11.001_bib1","first-page":"425","article-title":"Role of N-acetylcysteine in the management of COPD","volume":"1","author":"Sadowska","year":"2006","journal-title":"IntJ Chron Obstruct Pulmon Dis."},{"key":"10.1016\/j.clinthera.2010.11.001_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0149-2918(00)88479-9","article-title":"Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: A meta-analysis of published double-blind, placebo-controlled clinical trials","volume":"22","author":"Grandjean","year":"2000","journal-title":"Clin Ther."},{"key":"10.1016\/j.clinthera.2010.11.001_bib3","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.clinthera.2006.05.002","article-title":"Severe hepatotoxicity after therapeutic doses of acetaminophen","volume":"28","author":"Moling","year":"2006","journal-title":"Clin Ther."},{"key":"10.1016\/j.clinthera.2010.11.001_bib4","first-page":"265","article-title":"N-acetylcysteine: Multiple clinical applications","volume":"80","author":"Millea","year":"2009","journal-title":"Am Fam Physician."},{"key":"10.1016\/j.clinthera.2010.11.001_bib5","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.clinthera.2005.11.006","article-title":"Effects of antioxidant supplementa- tion on postprandial oxidative stress and endothelial dysfunction: A singleblind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls","volume":"27","author":"Neri","year":"2005","journal-title":"Clin Ther."},{"key":"10.1016\/j.clinthera.2010.11.001_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","article-title":"N-Acetyl-cysteine-a safe antidote for cysteine\/ glutathione deficiency","volume":"7","author":"Atkuri","year":"2007","journal-title":"Curr Opin Pharmacol."},{"key":"10.1016\/j.clinthera.2010.11.001_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jphotobiol.2003.06.004","article-title":"N-acetyl-L-cysteine prevents DNA damage induced by UVA, UVB and visible radiation in human fibroblasts","volume":"72","author":"Morley","year":"2003","journal-title":"J Photochem Photobiol B"},{"key":"10.1016\/j.clinthera.2010.11.001_bib8","first-page":"181","article-title":"Protective effect of N-acetylcysteine against gamma ray induced damages in rats\u2014biochemical evaluations","volume":"40","author":"Sridharan","year":"2002","journal-title":"Indian J Exp Biol."},{"key":"10.1016\/j.clinthera.2010.11.001_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1089-8603(02)00120-9","article-title":"Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis","volume":"7","author":"Failli","year":"2002","journal-title":"Nitric Oxide."},{"key":"10.1016\/j.clinthera.2010.11.001_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00003088-199120020-00004","article-title":"Clinical pharmacokinetics of N-acetylcysteine","volume":"20","author":"Holdiness","year":"1991","journal-title":"Clin Pharmacokinet."},{"key":"10.1016\/j.clinthera.2010.11.001_bib11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00228-004-0862-9","article-title":"Pharmacokinetics of intravenous N-acetylcysteine in men at rest and during exercise","volume":"60","author":"Brown","year":"2004","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2010.11.001_bib12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00228-004-0850-0","article-title":"Pharmacokinetics of N-acetylcysteine following repeated intravenous infusion in haemodialysed patients","volume":"60","author":"Soldini","year":"2005","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2010.11.001_bib13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s002280050687","article-title":"Pharmacokinetics of intravenous N-acetylcysteine in pre-term newborn infants","volume":"55","author":"Ahola","year":"1999","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2010.11.001_bib16","series-title":"Guideline for Good Clinical Practice. ICH topic E 6 (R1)","year":"2002"},{"key":"10.1016\/j.clinthera.2010.11.001_bib18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/bmc.1329","article-title":"Liquid chromatography tandem mass spectrometry method for determination of bisoprolol in human plasma using d5-bisoprolol as the internal standard","volume":"24","author":"Liu","year":"2010","journal-title":"Biomed Chromatogr."},{"key":"10.1016\/j.clinthera.2010.11.001_bib20","series-title":"Design and Analysis of Bioavailability and Bioequivalence Studies","first-page":"1","author":"Chow","year":"2000"},{"key":"10.1016\/j.clinthera.2010.11.001_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/bdd.2510120504","article-title":"Endogenous plasma N-acetylcysteine and single dose oral bioavailability from two different formulations as determined by a new analytical method","volume":"12","author":"Gabard","year":"1991","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.clinthera.2010.11.001_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00606662","article-title":"Pharmacokinetics of N-acetylcysteine in man","volume":"31","author":"Borgstr\u00f6m","year":"1986","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2010.11.001_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF01061422","article-title":"Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine","volume":"34","author":"Olsson","year":"1988","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2010.11.001_bib25","first-page":"382","article-title":"Pharmacokinetics and bioavailability of oral acetylcysteine in healthy volunteers","volume":"39","author":"De Caro","year":"1989","journal-title":"Arzneimittelforschung."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810003632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810003632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T16:21:27Z","timestamp":1711988487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291810003632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0149291810003632"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2010.11.001","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}